Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by longonMJon Nov 14, 2018 11:44pm
91 Views
Post# 28977681

RE:RE:RE:AURORA IS PROFITABLE And nobody else is

RE:RE:RE:AURORA IS PROFITABLE And nobody else is
hotdog123 wrote:
longonMJ wrote:
MRGreenthumb123 wrote: # 1 Cannibus company right now is is and we’re really undervalued should be at 16-20$ 


Well, this would most definitely appear to be the case if you was measuring the top weed companies based upon their top-line sales revenue, 

On a relative basis using this key sales revenue metric, Aurora would most definitely appear to be undervalued as its share price would be sitting at $20.10 based upon giving them the same valuation that Canopy received for their sales, or at $29.30 if it was based upon Tilray's valuation given to their sales.
 


Or the nay sayers would reply that ACB is perhaps the least overvalued!


Well, I definitely can't argue with this assessment either.  LOL

Fortunately for us then, in theory it should mean that Aurora has the lowest downside risk to its share price out of the big 3.   

Bullboard Posts